SciClone Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SciClone Pharmaceuticals with three other
companies in this sector in the United States:
sales of $165.44 million
Medicines Company (The)
of which 100%
was Development of Drugs), and
Avadel Pharmaceuticals PLC
SciClone Pharmaceuticals reported sales of $160.10 million
December of 2016.
a very small
increase of 1.8%
versus 2015, when the company's sales were $157.26 million.
This was the third consecutive year of growth at SciClone Pharmaceuticals.